KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.
Journal for immunotherapy of cancer(2023)
摘要
NCT01767194.
更多查看译文
关键词
Clinical Trials as Topic,Genetic Markers,Immunotherapy,Neuroblastoma,Pediatrics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要